drugset / Trial / NCT01974284

Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma

NCT01974284

Terminated 7 enrolled Yale University
NaSingle-groupOpen-labelTreatment

Summary

We assess the effectiveness of percutaneous ethanol ablation for the treatment of thyroid cancer.

Timeline

Start
2014-03
Primary completion
2017-03-02
Completion
2017-06-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Alcohol Other / unclassified Other